Literature DB >> 8120412

Chromosome 9 allele loss occurs in both basal and squamous cell carcinomas of the skin.

A G Quinn1, C Campbell, E Healy, J L Rees.   

Abstract

Linkage studies of kindreds with the nevoid basal cell carcinoma syndrome and the high frequency of chromosome 9 allele loss in sporadic basal cell carcinomas indicate that chromosome 9 may contain tumor suppressor genes important in the development of sporadic and familial basal cell carcinomas. The recent mapping of the Ferguson-Smith syndrome, which predisposes affected individuals to the development of multiple lesions histologically indistinguishable from squamous cell carcinomas, suggests that tumor suppressor genes on 9q may also be important in the development of squamous cell neoplasms of the skin. Fifty-four non-melanoma skin cancers (24 basal cell carcinomas, 14 squamous cell carcinomas, and 16 cases of Bowen's disease) were examined for loss of heterozygosity on chromosome 9. Allelic loss at one or more loci on chromosome 9 was observed in 14 of 24 basal cell carcinomas, four of 14 squamous cell carcinomas, and three of 16 cases of Bowen's disease. Allelic deletion of one or more 9q markers was seen in 14 basal cell carcinomas, three squamous cell carcinomas, and three cases of Bowen's disease. Five basal cell carcinomas had interstitial deletions and in one the breakpoint mapped within the nevoid basal cell carcinoma syndrome locus. 9p loss occurred in three of nine informative squamous cell carcinomas. Allelic deletion of 9p markers was not seen in 19 basal cell carcinomas and seven cases of Bowen's disease. These findings suggest that chromosome 9 contains one or more tumor suppressor genes important in the development of both basal and squamous cell carcinomas of the skin.

Entities:  

Mesh:

Year:  1994        PMID: 8120412     DOI: 10.1111/1523-1747.ep12371786

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.

Authors:  D P O'Connor; E W Kay; M Leader; G M Murphy; G J Atkins; M J Mabruk
Journal:  Mol Pathol       Date:  2001-06

2.  Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients.

Authors:  R Shimkets; M R Gailani; V M Siu; T Yang-Feng; C L Pressman; S Levanat; A Goldstein; M Dean; A E Bale
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

3.  Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.

Authors:  Sarah E Gray; Elaine Kay; Mary Leader; M Mabruk
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

Review 4.  Emerging concepts and recent advances in basal cell carcinoma.

Authors:  Mariam Totonchy; David Leffell
Journal:  F1000Res       Date:  2017-12-04

5.  Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.

Authors:  E Holmberg; B L Rozell; R Toftgård
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

6.  Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.

Authors:  A J Waring; M Takata; I Rehman; J L Rees
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

Review 7.  The Role of Dermal Fibroblasts in Nevoid Basal Cell Carcinoma Syndrome Patients: An Overview.

Authors:  Barbara Bellei; Silvia Caputo; Anna Carbone; Vitaliano Silipo; Federica Papaccio; Mauro Picardo; Laura Eibenschutz
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.